High-impact trials with genetic and-omics information focus on cancer mutations, are industry-funded and less transparent

L Russo, LM Siena, S Farina, R Pastorino… - Journal of Clinical …, 2025 - Elsevier
Objective To assess how genetics and-omics information is used in the most cited recent
clinical trials, and to evaluate industry involvement and transparency patterns. Study design …

Research Integrity in Emerging Technologies: Gene Editing and Artificial Intelligence (AI) Research in Medicine

B Redman - Reconstructing Research Integrity: Beyond Denial, 2023 - Springer
Emerging technologies challenge research integrity in several important ways. Technical
research and product development usually precede (often by several years) attention to …